Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E16.44 EPS (ttm)12.02 Insider Own0.20% Shs Outstand656.00M Perf Week1.00%
Market Cap129.60B Forward P/E13.63 EPS next Y14.50 Insider Trans-0.58% Shs Float646.03M Perf Month3.71%
Income8.46B PEG3.06 EPS next Q3.43 Inst Own81.00% Short Float1.55% Perf Quarter11.95%
Sales23.19B P/S5.59 EPS this Y7.30% Inst Trans-3.55% Short Ratio3.70 Perf Half Y7.97%
Book/sh22.73 P/B8.69 EPS next Y3.65% ROA3.20% Target Price204.26 Perf Year18.09%
Cash/sh44.81 P/C4.41 EPS next 5Y5.38% ROE10.70% 52W Range163.31 - 201.23 Perf YTD13.61%
Dividend5.28 P/FCF18.12 EPS past 5Y14.40% ROI14.00% 52W High-1.82% Beta1.41
Dividend %2.67% Quick Ratio3.10 Sales past 5Y5.80% Gross Margin82.70% 52W Low20.97% ATR3.07
Employees20800 Current Ratio3.40 Sales Q/Q4.30% Oper. Margin44.20% RSI (14)59.47 Volatility1.43% 1.65%
OptionableYes Debt/Eq2.31 EPS Q/Q19.40% Profit Margin10.20% Rel Volume0.63 Prev Close197.42
ShortableYes LT Debt/Eq2.03 EarningsJul 26 AMC Payout134.80% Avg Volume2.70M Price197.56
Recom2.30 SMA201.28% SMA503.49% SMA2009.04% Volume1,708,291 Change0.07%
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-20-16Initiated Credit Suisse Outperform $205
Aug-20-18 10:07AM  Amgen Stock Up This Year So Far: Will the Rally Continue? Zacks
Aug-17-18 07:30AM  [$$] Gormley's Take: Cancer-Killing Viruses Catch On With VCs The Wall Street Journal
Aug-15-18 08:51AM  Amgen: Cramer Discusses the AAP Portfolio's New Edition TheStreet.com
Aug-14-18 10:40AM  Top Research Reports: UnitedHealth, PepsiCo, Amgen & More Zacks
Aug-13-18 03:04PM  3 Strong Buy Stocks for the Week InvestorPlace
12:37PM  Amgen Inc (NASDAQ:AMGN): What You Have To Know Before Buying For The Upcoming Dividend Simply Wall St.
Aug-10-18 02:00PM  4 Biotech Stocks That May Fall By as Much as 13% Investopedia
01:56PM  Biotech ETFs in Focus on String of Q2 Earnings Beat Zacks
Aug-08-18 04:23PM  Mylan Exploring Options As 'Unsustainable' Trends Hound Sales, Profit Investor's Business Daily
01:39PM  Disney, Amgen Benefit From Shift to Value Stocks Investopedia
10:15AM  5 Companies Making Giant Buybacks InvestorPlace
09:17AM  Better Buy: Gilead Sciences, Inc. vs. Amgen Inc. Motley Fool
Aug-07-18 10:41AM  There's a big market shift coming and these stocks, including Disney, will benefit most CNBC
Aug-06-18 03:00PM  3 Healthcare Stocks to Buy for the Sector Rebound InvestorPlace
09:03AM  Zacks Investment Ideas feature highlights: Merck and Amgen Zacks
Aug-03-18 11:26AM  Two Pharma Giants Successfully Navigate a Challenging Climate Zacks
Aug-02-18 06:03PM  These are the 3 earnings losers to buy on the dip, says t... CNBC Videos
02:10PM  Moody's: US drug makers face heightened pricing pressure as regulatory risks pick up steam Moody's
Aug-01-18 09:34AM  Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit Zacks
Jul-31-18 04:15PM  Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island PR Newswire
04:00PM  Amgen Announces 2018 Third Quarter Dividend PR Newswire
03:29PM  Amgen Rises 3.01% As Investors Eye Earnings Investing.com
09:59AM  Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View Zacks
Jul-30-18 07:18PM  Edited Transcript of AMGN earnings conference call or presentation 26-Jul-18 9:00pm GMT Thomson Reuters StreetEvents
Jul-27-18 09:30AM  3 Best Ways to Play Amazon, Starbucks and Amgen After Earnings TheStreet.com
09:23AM  Amgen (AMGN) Q2 Earnings & Sales Beat Estimates, View Up Zacks
08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga
08:20AM  Today's Research Reports on Trending Tickers: Amgen and Clovis Oncology ACCESSWIRE
07:42AM  Stocks making the biggest moves premarket: TWTR, MRK, CL, AMZN, SBUX & more CNBC
01:01AM  PRESS DIGEST -Wall Street Journal - July 27 Reuters
Jul-26-18 08:16PM  Amgen Inc.'s Young Lineup Offsets Enbrel Losses With Style Motley Fool
07:50PM  [$$] Two Senior Amgen Executives to Leave The Wall Street Journal
06:33PM  Amgen profit beats Street view, will not raise prices again in 2018 Reuters
05:47PM  [$$] Two Senior Amgen Executives to Leave The Wall Street Journal
05:29PM  Amgen CEO says will not raise drug prices again this year Reuters
04:13PM  Amgen: 2Q Earnings Snapshot Associated Press
04:09PM  Amgen quarterly profit beats Wall Street view on new product sales Reuters
04:04PM  Amgen Replaces Two Top Executives, Beats Quarterly Estimates Bloomberg
04:02PM  Amgen Announces Succession Plans For Two Executive Officers PR Newswire
04:01PM  Amgen Reports Second Quarter 2018 Financial Results PR Newswire
08:40AM  Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold Benzinga
07:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
01:09AM  Focus: Amgen's new migraine drug hits insurance hurdles Reuters
01:00AM  FOCUS-Amgen's new migraine drug hits insurance hurdles Reuters
Jul-25-18 10:27AM  Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More Zacks
06:23AM  GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research CNBC
Jul-24-18 04:00PM  Amgen Announces Webcast of 2018 Second Quarter Financial Results PR Newswire
01:25PM  NYSE trader: Amazon, Visa and Twitter earnings are on my radartheir charts are very similar Yahoo Finance Video
Jul-23-18 11:10AM  Healthcare ETFs to Buy on Solid Q2 Earnings Expectations Zacks
06:33AM  AbbVie's Stock Is a Bargain After Falling 8% Last Week Motley Fool
Jul-20-18 05:43PM  Pfizer gets FDA approval for drug similar to Amgen's Neupogen MarketWatch
Jul-19-18 04:00PM  Amgen And Cedars-Sinai Partner For Improved Healthcare Quality PR Newswire
Jul-18-18 09:47AM  AbbVie Settles With Mylan to Delay Humira Biosimilar in U.S. Zacks
09:00AM  Former Major League Baseball (MLB) All-Stars Dave Winfield And Steve Garvey Team Up With Amgen To Launch Myeloma MVP And Encourage Patients To Create Their Most Valuable Plan For Managing Multiple Myeloma PR Newswire
08:08AM  Biotech Stock Roundup: AMGN Resubmits Evenity BLA, Advaxis Soars, Regulatory Updates Zacks
Jul-16-18 05:25PM  Pacira Focused on Exparel Development Amid Competition Zacks
08:31AM  Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population Zacks
Jul-15-18 08:00AM  Better Buy: Biogen Inc. vs. Amgen Motley Fool
Jul-13-18 10:15AM  Better Buy: Amgen Inc. vs. Johnson & Johnson Motley Fool
08:51AM  Is the Options Market Predicting a Spike in Amgen (AMGN) Stock? Zacks
08:34AM  Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering Benzinga
08:16AM  2 Overlooked Biotech Stocks to Buy Now Motley Fool
01:00AM  Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY (romosozumab) To The US FDA PR Newswire
Jul-12-18 01:30PM  7 High-Margin Stocks Poised to Beat the Market Investopedia
Jul-11-18 09:17AM  Your first trade for Wednesday, July 11 CNBC
09:15AM  3 Huge Biotech Winners in 2018 (So Far) Motley Fool
Jul-10-18 09:23AM  Moving Average Crossover Alert: Amgen (AMGN) Zacks
Jul-09-18 01:23PM  Bullish options traders target Amgen, this energy ETF CNBC Videos
08:00AM  Today's Research Reports on Stocks to Watch: Biogen and Amgen ACCESSWIRE
Jul-06-18 03:13PM  Why Biotech Stocks Rallied on Biogen's Alzheimer's Test Zacks
12:26PM  Biotech Stocks Rally on Biogen's Landmark Test TheStreet.com
12:05PM  Amgen Is Ready to Breakout on the Upside TheStreet.com
07:47AM  Zacks Industry Outlook Highlights: Amgen, ANI and Illumina Zacks
Jul-05-18 06:17PM  Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More Zacks
04:17PM  Biotech Stock Outlook: Short-Term Pricing Pain to Prevail Zacks
02:40PM  Drug pricing debate could heat up in July CNBC Videos
07:03AM  Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic Reuters
07:00AM  FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic Reuters
Jul-03-18 08:11AM  Amgen sues Durham generics company American City Business Journals
Jul-02-18 03:23PM  4 Drug and Biotech Stocks Awaiting FDA Decisions in July InvestorPlace
09:35AM  Should Value Investors Consider Amgen (AMGN) Stock Now? Zacks
Jul-01-18 06:32AM  Better Buy: Amgen Inc. vs. Pfizer Inc. Motley Fool
Jun-29-18 09:11AM  4 Biotech Stocks to Bet on in the Second Half of 2018 Zacks
08:30AM  Ron Squarer's risk-taking pays off at Array American City Business Journals
Jun-28-18 04:30PM  Amgen And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety And Tolerability Of Aimovig (erenumab-aooe) In Patients With Chronic And Episodic Migraine PR Newswire
11:10AM  5 Cheap Large Cap Stocks to Buy Now InvestorPlace
09:37AM  Mylan, Lupin Collaborate for the Proposed Biosimilar Enbrel Zacks
08:30AM  Amgen Announces Top-Line Data From Remicade Biosimilar Study Zacks
Jun-27-18 05:00PM  Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers PR Newswire
04:30PM  Amgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A Month PR Newswire
09:45AM  AMGN or ILMN: Which Is the Better Value Stock Right Now? Zacks
09:30AM  Has Amgen (AMGN) Outpaced Other Medical Stocks This Year? Zacks
09:00AM  Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab PR Newswire
08:24AM  The Zacks Analyst Blog Highlights: Facebook, Amgen, Abbott, Coca-Cola and 3M Zacks
08:12AM  Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod Zacks
Jun-26-18 11:12AM  Top Stock Reports for Facebook, Amgen & Abbott Zacks
07:58AM  Apple Led Company Stock Buybacks During Q1 Investopedia
Jun-25-18 09:39AM  Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes Zacks
07:00AM  Cambridge biotech startup grabs $65M to tackle liver disease American City Business Journals
Jun-24-18 06:32AM  Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines Motley Fool
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Aimovig for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc.; and The University of Texas MD Anderson Cancer Center. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM
Harper Sean EEVP, Research & DevelopmentJul 16Sale195.711,525298,45856,082Jul 16 08:20 PM
Harper Sean EEVP, Research & DevelopmentJun 12Sale184.271,525281,01257,510Jun 12 07:07 PM
Harper Sean EEVP, Research & DevelopmentMay 14Sale174.101,525265,50359,035May 15 07:52 PM
Piacquad DavidSVP, Business DevelopmentMay 11Option Exercise54.7115,000820,65051,566May 15 07:55 PM
Harper Sean EEVP, Research & DevelopmentApr 12Sale172.681,525263,33756,788Apr 16 07:03 PM
Harper Sean EEVP, Research & DevelopmentMar 16Sale189.751,525289,36965,682Mar 19 08:52 PM
Harper Sean EEVP, Research & DevelopmentFeb 14Sale174.181,525265,62552,089Feb 15 08:57 PM
Harper Sean EEVP, Research & DevelopmentJan 16Sale185.621,525283,07154,673Jan 17 08:19 PM
Harper Sean EEVP, Research & DevelopmentDec 12Sale176.831,525269,66656,106Dec 12 08:24 PM
Harper Sean EEVP, Research & DevelopmentNov 13Sale171.581,525261,66057,631Nov 14 07:27 PM
de Carbonnel FrancoisDirectorNov 08Sale173.614,000694,42215,528Nov 08 05:39 PM
Harper Sean EEVP, Research & DevelopmentOct 09Sale185.951,525283,57459,156Oct 10 08:29 PM